We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk of adverse clinical outcomes with concomitant use of clopidogrel and proton pump inhibitors following percutaneous coronary intervention.
- Authors
Gupta, Ekta; Bansal, Darpan; Sotos, John; Olden, Kevin
- Abstract
Recent studies have suggested that proton pump inhibitors (PPIs) attenuate the benefits of clopidogrel. The clinical relevance of this interaction in patients who have undergone percutaneous coronary intervention (PCI) is unknown. We hypothesized that post-PCI patients discharged on clopidogrel will have higher cardiovascular events if concomitant PPI therapy is used.
- Publication
Digestive diseases and sciences, 2010, Vol 55, Issue 7, p1964
- ISSN
1573-2568
- Publication type
Journal Article
- DOI
10.1007/s10620-009-0960-8